Micardis: Clinical Trials

23 trials of Micardis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 5 terminated, 2 recruiting, 1 enrolling by invitation. 8 Phase 2, 6 Phase 4, 5 Phase 1, 3 Phase 3, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 28Completed 4, Terminated 3, Recruiting 1
Phase 46Completed 4, Enrolling by invitation 1, Unknown 1
Phase 15Completed 4, Recruiting 1
Phase 33Completed 2, Terminated 1
Not applicable2Completed 1, Terminated 1

Follow Micardis: new trials by email Literature Review of Micardis trials Research Report on Micardis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes
Phase 4Enrolling by invitationBaylor Research Institute642026-04-082026-10-13
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
Telmisartan - Ovarian Cancer
Phase 2RecruitingTyler J Curiel332026-01-212026-01-28
Telmisartan in Prostate Cancer
Telmisartan, Standard of Care Regimen - Prostate Cancer
Phase 1RecruitingTyler J Curiel362024-04-222026-07-22
INvestigating TELmisartin Study
Telmisartan Oral Product, Placebo - Covid19
Phase 2TerminatedUniversity of Hawaii242021-09-012022-07-01
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet, Telmisartan 40Mg Oral Tablet, Atorvastatin 20 Mg Oral Tablet - COVID-19, COVID-19 Drug Treatment
Phase 2 / Phase 3CompletedANRS, Emerging Infectious Diseases2942020-11-272024-12-27
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Losartan, Valsartan, Azilsartan - Covid19, SARS-CoV Infection
Phase 3TerminatedUniversity of British Columbia3412020-10-092023-02-16
Telmisartan Pilot Study on Treatment Resistant Schizophrenia
Telmisartan Pill - Schizophrenia, Schizo Affective Disorder
Phase 2TerminatedXiaoduo Fan62019-02-012022-03-02
Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State
Telmisartan, Micardis - Bioequivalence
Phase 1CompletedPharmtechnology LLC262018-09-072018-12-27
Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease
Supervised Treadmill Exercise Therapy, Telmisartan, "No exercise" control group - Peripheral Artery Disease
Not applicableCompletedNorthwestern University1142016-01-042023-01-11
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Telmisartan - GVHD
Not applicableTerminatedHackensack Meridian Health322015-07-072026-04-02
Health Evaluation in African Americans Using RAS Therapy
Telmisartan 20mg, Telmisartan 40mg, Placebo - Alzheimer's Disease
Phase 1 / Phase 2CompletedEmory University612015-04-012024-05-23
CKD-828 (80/5mg) Pharmacokinetic Study
CKD-828, Telmisartan, S-amlodipine - Hypertension
Phase 1CompletedChong Kun Dang Pharmaceutical482015-02-012015-07-08
CKD-828 (80/5mg) Pharmacokinetic Study
CKD-828, Telmisartan, S-amlodipine - Hypertension
Phase 1CompletedChong Kun Dang Pharmaceutical692014-09-012015-04-10
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
Perindopril, Telmisartan - Alzheimer's Disease
Phase 2TerminatedSunnybrook Health Sciences Centre232014-03-012025-05-06
A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease
Telmisartan - Endothelial Dysfunction
Phase 2CompletedUniversity of California, Los Angeles172012-08-012014-12-08
HIGH Altitude CArdiovascular REsearch in the ANDES
Telmisartan, Nifedipine, placebo - Hypertension, High Altitude
Phase 4CompletedIstituto Auxologico Italiano1002012-05-012013-04-12
Comparative Study of the Effects of Telmisartan and Nebivolol
TELMISARTAN, NEBIVOLOL - Hypertension
Phase 4UnknownAristotle University Of Thessaloniki802010-12-012014-02-07
HIV and Fat Accumulation
Telmisartan - HIV Infection
Phase 2CompletedUniversity of California, Los Angeles352010-05-012019-02-04
Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients
captopril plus placebo, telmisartan plus placebo, Telmisartan plus Captopril - Inflammation, End-stage Renal Disease
Phase 4CompletedCoordinación de Investigación en Salud, Mexico602009-08-012018-12-19
Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients
Micardis - Hypertension
CompletedBoehringer Ingelheim6702009-04-012014-03-28

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Hypertension (8)  ·  COVID-19 (3)  ·  Alzheimer Disease (2)  ·  Cardiovascular Diseases (2)  ·  Inflammation (2)  ·  Kidney Failure, Chronic (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Albuminuria (1)  ·  Altitude Sickness (1)  ·  Coronavirus Infections (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Disease Progression (1)  ·  HIV Infections (1)  ·  Hyperkalemia (1)

Sponsors

Boehringer Ingelheim (3)  ·  Chong Kun Dang Pharmaceutical (2)  ·  Tyler J Curiel (2)  ·  University of California, Los Angeles (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Baylor Research Institute (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Emory University (1)  ·  Hackensack Meridian Health (1)  ·  Heidelberg University (1)  ·  Istituto Auxologico Italiano (1)  ·  Northwestern University (1)  ·  Pharmtechnology LLC (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

United States (11)  ·  Canada (4)  ·  France (4)  ·  South Korea (3)  ·  Germany (2)  ·  Greece (2)  ·  Italy (2)  ·  Mexico (2)  ·  Portugal (2)  ·  Sweden (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)

Top investigators

Young-Ran Yoon (2)  ·  Alfonso M. M Cueto-Manzano, MD, MSc, PhD (1)  ·  Cecilia M Shikuma (1)  ·  Eric Sicard, MD (1)  ·  Franz Schaefer, MD (1)  ·  Gianfranco Parati, MD, PhD (1)  ·  Ivy Wilkinson-Ryan, MD (1)  ·  James A Russell, MD (1)  ·  Jordan E. Lake, MD (1)  ·  Jordan Lake, M.D. (1)  ·  Karen Tran, MD (1)  ·  Krista Lanctot, PhD (1)  ·  Mary McDermott, MD (1)  ·  Otto Mehls, MD (1)

Results publications

PMID 14630977, PMID 14744931, PMID 15253732, PMID 15647341, PMID 15772249, PMID 16093916, PMID 18753638, PMID 18753639, PMID 18757238, PMID 22089721, PMID 22267825, PMID 22738922, PMID 22922507, PMID 23516440, PMID 23988639, PMID 25895588, PMID 27658740, PMID 29886423, PMID 36194220, PMID 37119829, PMID 39325643, PMID 39443527, PMID 42035974

NIH funding

1RF1AG051514 (1), R01HL126117 (1)